Xueyan Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xueyan Cao has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
- Xiangyang Shi
State Key Laboratory of Advanced Fiber Materials Shanghai Engineering Research Center of Nano‐Biomaterials and Regenerative Medicine College of Biological Science and Medical Engineering Donghua University Shanghai China
27 shared publications - Rui Guo
College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, People's Republic of China
21 shared publications Cheng Ni
Donghua University
6 shared publicationsYue Gao
6 shared publicationsZhijun Ouyang
6 shared publicationsHonghua Guo
5 shared publications
Latest Publications
- 11 September 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (37) , 25512-25530
Biomimetic Dual-Driven Janus Nanorobots for Enhanced Penetration and Combined Gas/Photothermal/Photodynamic/Catalytic Therapy of Pancreatic Cancer
Pancreatic cancer (PC) remains an extremely lethal malignancy due to its dense desmoplastic stroma and aberrant tumor microenvironment (TME), which severely impedes the efficacy of conventional therapies. Herein, a biomimetic dual-driven Janus nanorobot (rCeGLI@PM) is strategically constructed via the asymmetric decoration of l-arginine (l-Arg)-functionalized and indocyanine green (ICG)-loaded poly(amidoamine) dendrimers onto CeOx nanozymes, followed by homologous Panc02 cell membrane camouflage. The formed nanorobots exhibit precise tumor accumulation via homologous targeting and deep penetration through NIR-induced thermophoresis and gas generation propulsion. Within the TME, nanorobots initiate cascade catalysis that generates toxic hydroxyl radicals and depletes glutathione to exaggerate oxidative stress while replenishing oxygen to alleviate tumor hypoxia and amplify photodynamic therapy (PDT). Meanwhile, NIR-triggered photothermal therapy (PTT) accelerates the nanozymatic activity for enhanced catalytic therapy, and PDT-triggered NO forms peroxynitrite (ONOO–) to degrade the extracellular matrix. This establishes a self-amplifying feedback loop for enhanced intratumoral infiltration and overall therapeutic efficacy. Comprehensive evaluations in subcutaneous and orthotopic PC models confirmed that rCeGLI@PM achieved superior therapeutic outcomes through synergistic PTT/PDT/gas/catalytic therapy. In summary, the strategic asymmetrical decoration of multifunctional dendrimers on nanozymes establishes a facile and versatile paradigm for engineering self-propelled nanorobots capable of multimodal synergistic therapies.
- 11 September 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (37) , 25512-25530
Biomimetic Dual-Driven Janus Nanorobots for Enhanced Penetration and Combined Gas/Photothermal/Photodynamic/Catalytic Therapy of Pancreatic Cancer
Pancreatic cancer (PC) remains an extremely lethal malignancy due to its dense desmoplastic stroma and aberrant tumor microenvironment (TME), which severely impedes the efficacy of conventional therapies. Herein, a biomimetic dual-driven Janus nanorobot (rCeGLI@PM) is strategically constructed via the asymmetric decoration of l-arginine (l-Arg)-functionalized and indocyanine green (ICG)-loaded poly(amidoamine) dendrimers onto CeOx nanozymes, followed by homologous Panc02 cell membrane camouflage. The formed nanorobots exhibit precise tumor accumulation via homologous targeting and deep penetration through NIR-induced thermophoresis and gas generation propulsion. Within the TME, nanorobots initiate cascade catalysis that generates toxic hydroxyl radicals and depletes glutathione to exaggerate oxidative stress while replenishing oxygen to alleviate tumor hypoxia and amplify photodynamic therapy (PDT). Meanwhile, NIR-triggered photothermal therapy (PTT) accelerates the nanozymatic activity for enhanced catalytic therapy, and PDT-triggered NO forms peroxynitrite (ONOO–) to degrade the extracellular matrix. This establishes a self-amplifying feedback loop for enhanced intratumoral infiltration and overall therapeutic efficacy. Comprehensive evaluations in subcutaneous and orthotopic PC models confirmed that rCeGLI@PM achieved superior therapeutic outcomes through synergistic PTT/PDT/gas/catalytic therapy. In summary, the strategic asymmetrical decoration of multifunctional dendrimers on nanozymes establishes a facile and versatile paradigm for engineering self-propelled nanorobots capable of multimodal synergistic therapies.
- 18 May 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (13) , 3481-3494
Integrated cascade catalysis of AuPtCu nanozymes and glycolysis inhibition for synergistic breast cancer therapy via metabolism regulation
Nanozymes have emerged as powerful therapeutic agents due to their robust catalytic performance, but their efficacy is often constrained by the complex tumor microenvironment (TME) and the unique metabolic pathway of cancer cells. To overcome this circumstance, a multifunctional nanoplatform (G5.NHAc-PG@APC) was developed to integrate targeted triple-enzyme cascade catalysis with responsive glycolytic inhibition. By using phenylboronic acid (PBA)-modified G5 PAMAM dendrimers as targeted nanocarriers, trimetallic AuPtCu nanozymes were encapsulated, followed by conjugating the glycolytic inhibitor 2-deoxy-D-glucose (2-DG) via pH-responsive boronate ester linkages. The resulting G5.NHAc-PG@APC nanoplatform could target sialic acid-overexpressing tumor cells and exhibit triple SOD/CAT/POD-like enzymatic activities for cascade catalytic therapy to effectively convert endogenous superoxide anions and hydrogen peroxide into lethal hydroxyl radicals (˙OH) while simultaneously generating oxygen to alleviate tumor hypoxia. Furthermore, the co-delivered 2-DG could be responsively released at the TME to inhibit aerobic glycolysis, thereby depriving the intracellular adenosine triphosphate (ATP) and reducing the generation of glutathione (GSH). In vivo studies in a 4T1 tumor-bearing mouse model confirmed that this synergistic strategy of metabolic starvation and sustained oxidative stress could effectively inhibit tumor growth and suppress pulmonary metastasis, while alleviating hypoxia. This work provides a versatile framework for the design of multimetallic nanozymes and multi-pathway synergistic strategies for advanced cancer therapy.
- 18 May 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (13) , 3481-3494
Integrated cascade catalysis of AuPtCu nanozymes and glycolysis inhibition for synergistic breast cancer therapy via metabolism regulation
Nanozymes have emerged as powerful therapeutic agents due to their robust catalytic performance, but their efficacy is often constrained by the complex tumor microenvironment (TME) and the unique metabolic pathway of cancer cells. To overcome this circumstance, a multifunctional nanoplatform (G5.NHAc-PG@APC) was developed to integrate targeted triple-enzyme cascade catalysis with responsive glycolytic inhibition. By using phenylboronic acid (PBA)-modified G5 PAMAM dendrimers as targeted nanocarriers, trimetallic AuPtCu nanozymes were encapsulated, followed by conjugating the glycolytic inhibitor 2-deoxy-D-glucose (2-DG) via pH-responsive boronate ester linkages. The resulting G5.NHAc-PG@APC nanoplatform could target sialic acid-overexpressing tumor cells and exhibit triple SOD/CAT/POD-like enzymatic activities for cascade catalytic therapy to effectively convert endogenous superoxide anions and hydrogen peroxide into lethal hydroxyl radicals (˙OH) while simultaneously generating oxygen to alleviate tumor hypoxia. Furthermore, the co-delivered 2-DG could be responsively released at the TME to inhibit aerobic glycolysis, thereby depriving the intracellular adenosine triphosphate (ATP) and reducing the generation of glutathione (GSH). In vivo studies in a 4T1 tumor-bearing mouse model confirmed that this synergistic strategy of metabolic starvation and sustained oxidative stress could effectively inhibit tumor growth and suppress pulmonary metastasis, while alleviating hypoxia. This work provides a versatile framework for the design of multimetallic nanozymes and multi-pathway synergistic strategies for advanced cancer therapy.
- Open Access
- 19 October 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 305, 119261
Mechanistic insights into Diuron-induced acute renal injury: Integration of network toxicology and experimental validation
- 19 October 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 305, 119261
Open AccessMechanistic insights into Diuron-induced acute renal injury: Integration of network toxicology and experimental validation
- 4 August 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (32) , 46458-46459
Correction to “Dual-Responsive Core–Shell Tecto Dendrimers Enable Efficient Gene Editing of Cancer Cells to Boost Immune Checkpoint Blockade Therapy”
- 4 August 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (32) , 46458-46459
Correction to “Dual-Responsive Core–Shell Tecto Dendrimers Enable Efficient Gene Editing of Cancer Cells to Boost Immune Checkpoint Blockade Therapy”
- 20 June 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26 (7) , 4529-4543
Biomimetic Chitosan Nanogels Codeliver Drug/Small Activating RNA for Metastasis-Inhibited Necroptosis Therapy of Ovarian Cancer
Ovarian cancer remains the leading cause of gynecologic malignancy-related deaths. Developing novel nanoplatforms to overcome the low efficacy of chemotherapy and advanced metastasis in ovarian cancer is crucial. Here, we report biomimetic chitosan nanogels (CH NGs) designed to codeliver gambogic acid (GA) and MAS1 small activating RNA (saMAS1). The formed CH NGs/GA/saMAS1 camouflaged with ovarian cancer cell membranes (CM) can release GA in a pH-responsive manner, target cancer cells, and induce the killing effects through GA-mediated necroptosis. Meanwhile, saMAS1 upregulates MAS1 expression, counteracting the activation of angiotensin II receptor type 1 (AGTR1) and thereby inhibiting the renin-angiotensin system (RAS) signaling pathway, subsequently impeding metastasis. The therapeutic efficacy of CH NGs/GA/saMAS1@CM NGs regarding primary tumor killing and metastasis inhibition was further confirmed using ovarian mouse models. These biocompatible CH NGs represent a promising advanced nanomedicine formulation to tackle ovarian cancer through metastasis-inhibited necroptosis following the codelivery of GA and saMAS1.
- 20 June 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26 (7) , 4529-4543
Biomimetic Chitosan Nanogels Codeliver Drug/Small Activating RNA for Metastasis-Inhibited Necroptosis Therapy of Ovarian Cancer
Ovarian cancer remains the leading cause of gynecologic malignancy-related deaths. Developing novel nanoplatforms to overcome the low efficacy of chemotherapy and advanced metastasis in ovarian cancer is crucial. Here, we report biomimetic chitosan nanogels (CH NGs) designed to codeliver gambogic acid (GA) and MAS1 small activating RNA (saMAS1). The formed CH NGs/GA/saMAS1 camouflaged with ovarian cancer cell membranes (CM) can release GA in a pH-responsive manner, target cancer cells, and induce the killing effects through GA-mediated necroptosis. Meanwhile, saMAS1 upregulates MAS1 expression, counteracting the activation of angiotensin II receptor type 1 (AGTR1) and thereby inhibiting the renin-angiotensin system (RAS) signaling pathway, subsequently impeding metastasis. The therapeutic efficacy of CH NGs/GA/saMAS1@CM NGs regarding primary tumor killing and metastasis inhibition was further confirmed using ovarian mouse models. These biocompatible CH NGs represent a promising advanced nanomedicine formulation to tackle ovarian cancer through metastasis-inhibited necroptosis following the codelivery of GA and saMAS1.
- 19 May 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (21) , 30716-30730
Dendrimer-Entrapped CuPt Bimetallic Nanozymes for Tumor Microenvironment-Regulated Photothermal/Catalytic Therapy
Noble metal nanozymes have attracted extensive attention in tumor therapy due to their multiple enzyme-like activities for catalytic therapy and unique optical properties for photothermal therapy (PTT). However, their therapeutic efficiency may be compromised by the intricate tumor microenvironment (TME). Herein, copper-platinum (CuPt) bimetallic nanozymes were synthesized and entrapped by poly(amidoamine) dendrimers, with p-carboxybenzenesulfonamide (BS, a carbonic anhydrase IX (CA IX) inhibitor) modified on the surface and lonidamine (Lon) loaded inside to regulate TME for enhanced catalytic therapy and PTT. The formed CPL@G5-BS nanozymes could specifically target CA IX-overexpressed tumor cells and activate the cascade catalytic reaction with continuous •OH generation by the peroxidase-like property, O2 supply by the catalase-like property, and H2O2 replenishing by the superoxide dismutase-like property, thereby alleviating hypoxia and achieving chemodynamic therapy (CDT). In the TME, BS-mediated CA IX inhibition would normalize the extracellular pH to suppress metastasis while reducing the intracellular pH to boost the catalytic efficiency, and Lon-mediated mitochondrial respiration inhibition and energy metabolic disruption would elevate intracellular oxygen accumulation and downregulate heat shock protein (HSP) expression, further enhancing the PTT efficacy. Meanwhile, the excellent photothermal performance of CPL@G5-BS could amplify the multienzyme activities, and Cu2+-mediated glutathione depletion further improved the CDT efficiency. Overall, the CPL@G5-BS nanozymes can efficiently inhibit tumor growth and suppress metastasis by TME-regulated catalytic therapy and PTT.
- 19 May 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (21) , 30716-30730
Dendrimer-Entrapped CuPt Bimetallic Nanozymes for Tumor Microenvironment-Regulated Photothermal/Catalytic Therapy
Noble metal nanozymes have attracted extensive attention in tumor therapy due to their multiple enzyme-like activities for catalytic therapy and unique optical properties for photothermal therapy (PTT). However, their therapeutic efficiency may be compromised by the intricate tumor microenvironment (TME). Herein, copper-platinum (CuPt) bimetallic nanozymes were synthesized and entrapped by poly(amidoamine) dendrimers, with p-carboxybenzenesulfonamide (BS, a carbonic anhydrase IX (CA IX) inhibitor) modified on the surface and lonidamine (Lon) loaded inside to regulate TME for enhanced catalytic therapy and PTT. The formed CPL@G5-BS nanozymes could specifically target CA IX-overexpressed tumor cells and activate the cascade catalytic reaction with continuous •OH generation by the peroxidase-like property, O2 supply by the catalase-like property, and H2O2 replenishing by the superoxide dismutase-like property, thereby alleviating hypoxia and achieving chemodynamic therapy (CDT). In the TME, BS-mediated CA IX inhibition would normalize the extracellular pH to suppress metastasis while reducing the intracellular pH to boost the catalytic efficiency, and Lon-mediated mitochondrial respiration inhibition and energy metabolic disruption would elevate intracellular oxygen accumulation and downregulate heat shock protein (HSP) expression, further enhancing the PTT efficacy. Meanwhile, the excellent photothermal performance of CPL@G5-BS could amplify the multienzyme activities, and Cu2+-mediated glutathione depletion further improved the CDT efficiency. Overall, the CPL@G5-BS nanozymes can efficiently inhibit tumor growth and suppress metastasis by TME-regulated catalytic therapy and PTT.
- 19 May 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (22) , 32013-32027
Mesenchymal Stem-Cell-Derived Exosomes Loaded with Phosphorus Dendrimers and Quercetin Treat Parkinson’s Disease by Modulating Inflammatory Immune Microenvironment
The intricate pathologic features of Parkinson's disease (PD) coupled with the obstacle posed by the blood-brain barrier (BBB) significantly limit the efficacy of most medications, leading to difficulties in PD treatments. Herein, we have developed a nanomedicine based on stem-cell-derived exosomes coloaded with hydroxyl-terminated phosphorus dendrimers (AK76) and quercetin (Que) for combined therapeutic intervention of PD. The engineered nanocomplexes (for short, QAE NPs) exhibit an optimal size of 269.7 nm, favorable drug release profile, and desired cytocompatibility, enabling penetration of the nasal mucosa to accumulate in the brain without BBB crossing. The developed QAE NPs can scavenge reactive oxygen species, promote M2 microglial polarization, attenuate inflammation, and protect neurons by inducing autophagy and restoring mitochondrial homeostasis through the integrated anti-inflammatory and antioxidant properties of exosomes, Que and AK76, collectively leading to improved motor functions, coordination, and alleviation of depression-like symptoms in PD mice. The formulated QAE NPs combined with several therapeutic components are able to simultaneously modulate both microglia and neurons, offering promising potential for the treatment of PD and other neurodegenerative disorders.
- 19 May 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (22) , 32013-32027
Mesenchymal Stem-Cell-Derived Exosomes Loaded with Phosphorus Dendrimers and Quercetin Treat Parkinson’s Disease by Modulating Inflammatory Immune Microenvironment
The intricate pathologic features of Parkinson's disease (PD) coupled with the obstacle posed by the blood-brain barrier (BBB) significantly limit the efficacy of most medications, leading to difficulties in PD treatments. Herein, we have developed a nanomedicine based on stem-cell-derived exosomes coloaded with hydroxyl-terminated phosphorus dendrimers (AK76) and quercetin (Que) for combined therapeutic intervention of PD. The engineered nanocomplexes (for short, QAE NPs) exhibit an optimal size of 269.7 nm, favorable drug release profile, and desired cytocompatibility, enabling penetration of the nasal mucosa to accumulate in the brain without BBB crossing. The developed QAE NPs can scavenge reactive oxygen species, promote M2 microglial polarization, attenuate inflammation, and protect neurons by inducing autophagy and restoring mitochondrial homeostasis through the integrated anti-inflammatory and antioxidant properties of exosomes, Que and AK76, collectively leading to improved motor functions, coordination, and alleviation of depression-like symptoms in PD mice. The formulated QAE NPs combined with several therapeutic components are able to simultaneously modulate both microglia and neurons, offering promising potential for the treatment of PD and other neurodegenerative disorders.
- 5 September 2024
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (10) , 6594-6602
Rapid Real-Time PCR Based on Core–Shell Tecto-Dendrimer-Entrapped Au Nanoparticles
Rapid real-time PCR (generally <1 h) has broad prospects. In this study, we synthesized a new type of nanomaterial core-shell tecto-dendrimer coated with Au nanoparticles (Au CSTDs) for research in this field. The experimental results showed that Au CSTDs could significantly shorten the time of real-time PCR (from 72 to 28 min) with different templates, while the detection limit reached 10 copies and the nonspecific amplification was significantly reduced. Furthermore, experimental analyses and theoretical studies using the finite element simulation method confirmed that Au CSTDs function by synergistically enhancing electrostatic adsorption and thermal conductivity. These properties play a key role in improving real-time PCR, especially in particle-particle interactions. This study contributes an advanced method to rapid real-time PCR, which is expected to remarkably improve the efficiency, lower the detection limit, and enhance the specificity of molecular detection.
- 5 September 2024
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (10) , 6594-6602
Rapid Real-Time PCR Based on Core–Shell Tecto-Dendrimer-Entrapped Au Nanoparticles
Rapid real-time PCR (generally <1 h) has broad prospects. In this study, we synthesized a new type of nanomaterial core-shell tecto-dendrimer coated with Au nanoparticles (Au CSTDs) for research in this field. The experimental results showed that Au CSTDs could significantly shorten the time of real-time PCR (from 72 to 28 min) with different templates, while the detection limit reached 10 copies and the nonspecific amplification was significantly reduced. Furthermore, experimental analyses and theoretical studies using the finite element simulation method confirmed that Au CSTDs function by synergistically enhancing electrostatic adsorption and thermal conductivity. These properties play a key role in improving real-time PCR, especially in particle-particle interactions. This study contributes an advanced method to rapid real-time PCR, which is expected to remarkably improve the efficiency, lower the detection limit, and enhance the specificity of molecular detection.